Skip to main content
profile image
Selected Works of Jerome Goldschmidt, MD
Article
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients
NPJ breast cancer (2019)
  • Devchand Paul, US Oncology Research, Inc., The Woodlands, USA
  • Svetislava J. Vukelja, Texas Oncology
  • Frankie Ann Holmes, Texas Oncology
  • Joanne L. Blum, Baylor University Medical Center
  • Kristi J. McIntyre, NewYork–Presbyterian Hospital
  • Deborah L. Lindquist, US Oncology Research, Inc., The Woodlands, USA
  • Cynthia R. Osborne, Baylor University Medical Center
  • Ines J. Sanchez, Texas Oncology
  • Jerome H. Goldschmidt, US Oncology Research, Inc., The Woodlands, USA
  • Yunfei Wang, 1US Oncology Research, Inc., 10101 Woodloch Forest Dr., The Woodlands, TX 77380 USA.
  • Lina Asmar, 1US Oncology Research, Inc., 10101 Woodloch Forest Dr., The Woodlands, TX 77380 USA.
  • Lewis Strauss, Bristol-Myers Squibb
  • Joyce O’Shaughnessy, Baylor University Medical Center
Link
Disciplines
Publication Date
October 28, 2019
DOI
10.1038/S41523-019-0132-8
Citation Information
Devchand Paul, Svetislava J. Vukelja, Frankie Ann Holmes, Joanne L. Blum, et al.. "Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients" NPJ breast cancer Vol. 5 Iss. 1 (2019) p. 36
Available at: http://works.bepress.com/jerome-goldschmidt/14/